10% Dextrose Injection - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

Publication ID:

PB511244843

Publication Date:

November 12, 2024

Pages:

101

Publisher:

MRRPB5

Countries:

Global [1]

USD 3,950.00

Healthcare [2]

Pharma & Healthcare [3]

Description:

Dextrose injection is a sterile solution used to provide your body with extra water and carbohydrates (calories from sugar). It is used when a patient is not able to drink enough liquids or when additional fluids are needed. 10% Dextrose Injection are indicated for use in adults and pediatric patients as sources of calories and water for hydration.
The global market for 10% Dextrose Injection was estimated to be worth US$ million in 2023 and is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during the forecast period 2024-2030.
North American market for 10% Dextrose Injection was valued at $ million in 2023 and will reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for 10% Dextrose Injection was valued at $ million in 2023 and will reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Europe market for 10% Dextrose Injection was valued at $ million in 2023 and will reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The global key companies of 10% Dextrose Injection include B. Braun Medical Inc, ICU Medical, Baxter, Fresenius Kabi, Pfizer, Alfa Laboratories, Drugfield Pharmaceuticals Limited, Otsuka Pharmaceutical and Schwitz Biotech, etc. In 2023, the global five largest players hold a share approximately % in terms of revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for 10% Dextrose Injection, focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of 10% Dextrose Injection by region & country, by Type, and by Application.
The 10% Dextrose Injection market size, estimations, and forecasts are provided in terms of sales volume (KL) and sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding 10% Dextrose Injection.
Market Segmentation
By Company
B. Braun Medical Inc
ICU Medical
Baxter
Fresenius Kabi
Pfizer
Alfa Laboratories
Drugfield Pharmaceuticals Limited
Otsuka Pharmaceutical
Schwitz Biotech
Segment by Type:
250 mL
500 mL
1000 mL
Segment by Application
First-Aid Treatment
Sports
Trophotherapy
Others
By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, global total market size (valve, volume and price). This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of 10% Dextrose Injection manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Sales, revenue of 10% Dextrose Injection in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Sales, revenue of 10% Dextrose Injection in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 Market Overview
1.1 10% Dextrose Injection Product Introduction
1.2 Global 10% Dextrose Injection Market Size Forecast
1.2.1 Global 10% Dextrose Injection Sales Value (2019-2030)
1.2.2 Global 10% Dextrose Injection Sales Volume (2019-2030)
1.2.3 Global 10% Dextrose Injection Sales Price (2019-2030)
1.3 10% Dextrose Injection Market Trends & Drivers
1.3.1 10% Dextrose Injection Industry Trends
1.3.2 10% Dextrose Injection Market Drivers & Opportunity
1.3.3 10% Dextrose Injection Market Challenges
1.3.4 10% Dextrose Injection Market Restraints
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global 10% Dextrose Injection Players Revenue Ranking (2023)
2.2 Global 10% Dextrose Injection Revenue by Company (2019-2024)
2.3 Global 10% Dextrose Injection Players Sales Volume Ranking (2023)
2.4 Global 10% Dextrose Injection Sales Volume by Company Players (2019-2024)
2.5 Global 10% Dextrose Injection Average Price by Company (2019-2024)
2.6 Key Manufacturers 10% Dextrose Injection Manufacturing Base Distribution and Headquarters
2.7 Key Manufacturers 10% Dextrose Injection Product Offered
2.8 Key Manufacturers Time to Begin Mass Production of 10% Dextrose Injection
2.9 10% Dextrose Injection Market Competitive Analysis
2.9.1 10% Dextrose Injection Market Concentration Rate (2019-2024)
2.9.2 Global 5 and 10 Largest Manufacturers by 10% Dextrose Injection Revenue in 2023
2.9.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in 10% Dextrose Injection as of 2023)
2.10 Mergers & Acquisitions, Expansion
3 Segmentation by Type
3.1 Introduction by Type
3.1.1 250 mL
3.1.2 500 mL
3.1.3 1000 mL
3.2 Global 10% Dextrose Injection Sales Value by Type
3.2.1 Global 10% Dextrose Injection Sales Value by Type (2019 VS 2023 VS 2030)
3.2.2 Global 10% Dextrose Injection Sales Value, by Type (2019-2030)
3.2.3 Global 10% Dextrose Injection Sales Value, by Type (%) (2019-2030)
3.3 Global 10% Dextrose Injection Sales Volume by Type
3.3.1 Global 10% Dextrose Injection Sales Volume by Type (2019 VS 2023 VS 2030)
3.3.2 Global 10% Dextrose Injection Sales Volume, by Type (2019-2030)
3.3.3 Global 10% Dextrose Injection Sales Volume, by Type (%) (2019-2030)
3.4 Global 10% Dextrose Injection Average Price by Type (2019-2030)
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 First-Aid Treatment
4.1.2 Sports
4.1.3 Trophotherapy
4.1.4 Others
4.2 Global 10% Dextrose Injection Sales Value by Application
4.2.1 Global 10% Dextrose Injection Sales Value by Application (2019 VS 2023 VS 2030)
4.2.2 Global 10% Dextrose Injection Sales Value, by Application (2019-2030)
4.2.3 Global 10% Dextrose Injection Sales Value, by Application (%) (2019-2030)
4.3 Global 10% Dextrose Injection Sales Volume by Application
4.3.1 Global 10% Dextrose Injection Sales Volume by Application (2019 VS 2023 VS 2030)
4.3.2 Global 10% Dextrose Injection Sales Volume, by Application (2019-2030)
4.3.3 Global 10% Dextrose Injection Sales Volume, by Application (%) (2019-2030)
4.4 Global 10% Dextrose Injection Average Price by Application (2019-2030)
5 Segmentation by Region
5.1 Global 10% Dextrose Injection Sales Value by Region
5.1.1 Global 10% Dextrose Injection Sales Value by Region: 2019 VS 2023 VS 2030
5.1.2 Global 10% Dextrose Injection Sales Value by Region (2019-2024)
5.1.3 Global 10% Dextrose Injection Sales Value by Region (2025-2030)
5.1.4 Global 10% Dextrose Injection Sales Value by Region (%), (2019-2030)
5.2 Global 10% Dextrose Injection Sales Volume by Region
5.2.1 Global 10% Dextrose Injection Sales Volume by Region: 2019 VS 2023 VS 2030
5.2.2 Global 10% Dextrose Injection Sales Volume by Region (2019-2024)
5.2.3 Global 10% Dextrose Injection Sales Volume by Region (2025-2030)
5.2.4 Global 10% Dextrose Injection Sales Volume by Region (%), (2019-2030)
5.3 Global 10% Dextrose Injection Average Price by Region (2019-2030)
5.4 North America
5.4.1 North America 10% Dextrose Injection Sales Value, 2019-2030
5.4.2 North America 10% Dextrose Injection Sales Value by Country (%), 2023 VS 2030
5.5 Europe
5.5.1 Europe 10% Dextrose Injection Sales Value, 2019-2030
5.5.2 Europe 10% Dextrose Injection Sales Value by Country (%), 2023 VS 2030
5.6 Asia Pacific
5.6.1 Asia Pacific 10% Dextrose Injection Sales Value, 2019-2030
5.6.2 Asia Pacific 10% Dextrose Injection Sales Value by Country (%), 2023 VS 2030
5.7 South America
5.7.1 South America 10% Dextrose Injection Sales Value, 2019-2030
5.7.2 South America 10% Dextrose Injection Sales Value by Country (%), 2023 VS 2030
5.8 Middle East & Africa
5.8.1 Middle East & Africa 10% Dextrose Injection Sales Value, 2019-2030
5.8.2 Middle East & Africa 10% Dextrose Injection Sales Value by Country (%), 2023 VS 2030
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions 10% Dextrose Injection Sales Value Growth Trends, 2019 VS 2023 VS 2030
6.2 Key Countries/Regions 10% Dextrose Injection Sales Value
6.2.1 Key Countries/Regions 10% Dextrose Injection Sales Value, 2019-2030
6.2.2 Key Countries/Regions 10% Dextrose Injection Sales Volume, 2019-2030
6.3 United States
6.3.1 United States 10% Dextrose Injection Sales Value, 2019-2030
6.3.2 United States 10% Dextrose Injection Sales Value by Type (%), 2023 VS 2030
6.3.3 United States 10% Dextrose Injection Sales Value by Application, 2023 VS 2030
6.4 Europe
6.4.1 Europe 10% Dextrose Injection Sales Value, 2019-2030
6.4.2 Europe 10% Dextrose Injection Sales Value by Type (%), 2023 VS 2030
6.4.3 Europe 10% Dextrose Injection Sales Value by Application, 2023 VS 2030
6.5 China
6.5.1 China 10% Dextrose Injection Sales Value, 2019-2030
6.5.2 China 10% Dextrose Injection Sales Value by Type (%), 2023 VS 2030
6.5.3 China 10% Dextrose Injection Sales Value by Application, 2023 VS 2030
6.6 Japan
6.6.1 Japan 10% Dextrose Injection Sales Value, 2019-2030
6.6.2 Japan 10% Dextrose Injection Sales Value by Type (%), 2023 VS 2030
6.6.3 Japan 10% Dextrose Injection Sales Value by Application, 2023 VS 2030
6.7 South Korea
6.7.1 South Korea 10% Dextrose Injection Sales Value, 2019-2030
6.7.2 South Korea 10% Dextrose Injection Sales Value by Type (%), 2023 VS 2030
6.7.3 South Korea 10% Dextrose Injection Sales Value by Application, 2023 VS 2030
6.8 Southeast Asia
6.8.1 Southeast Asia 10% Dextrose Injection Sales Value, 2019-2030
6.8.2 Southeast Asia 10% Dextrose Injection Sales Value by Type (%), 2023 VS 2030
6.8.3 Southeast Asia 10% Dextrose Injection Sales Value by Application, 2023 VS 2030
6.9 India
6.9.1 India 10% Dextrose Injection Sales Value, 2019-2030
6.9.2 India 10% Dextrose Injection Sales Value by Type (%), 2023 VS 2030
6.9.3 India 10% Dextrose Injection Sales Value by Application, 2023 VS 2030
7 Company Profiles
7.1 B. Braun Medical Inc
7.1.1 B. Braun Medical Inc Company Information
7.1.2 B. Braun Medical Inc Introduction and Business Overview
7.1.3 B. Braun Medical Inc 10% Dextrose Injection Sales, Revenue and Gross Margin (2019-2024)
7.1.4 B. Braun Medical Inc 10% Dextrose Injection Product Offerings
7.1.5 B. Braun Medical Inc Recent Development
7.2 ICU Medical
7.2.1 ICU Medical Company Information
7.2.2 ICU Medical Introduction and Business Overview
7.2.3 ICU Medical 10% Dextrose Injection Sales, Revenue and Gross Margin (2019-2024)
7.2.4 ICU Medical 10% Dextrose Injection Product Offerings
7.2.5 ICU Medical Recent Development
7.3 Baxter
7.3.1 Baxter Company Information
7.3.2 Baxter Introduction and Business Overview
7.3.3 Baxter 10% Dextrose Injection Sales, Revenue and Gross Margin (2019-2024)
7.3.4 Baxter 10% Dextrose Injection Product Offerings
7.3.5 Baxter Recent Development
7.4 Fresenius Kabi
7.4.1 Fresenius Kabi Company Information
7.4.2 Fresenius Kabi Introduction and Business Overview
7.4.3 Fresenius Kabi 10% Dextrose Injection Sales, Revenue and Gross Margin (2019-2024)
7.4.4 Fresenius Kabi 10% Dextrose Injection Product Offerings
7.4.5 Fresenius Kabi Recent Development
7.5 Pfizer
7.5.1 Pfizer Company Information
7.5.2 Pfizer Introduction and Business Overview
7.5.3 Pfizer 10% Dextrose Injection Sales, Revenue and Gross Margin (2019-2024)
7.5.4 Pfizer 10% Dextrose Injection Product Offerings
7.5.5 Pfizer Recent Development
7.6 Alfa Laboratories
7.6.1 Alfa Laboratories Company Information
7.6.2 Alfa Laboratories Introduction and Business Overview
7.6.3 Alfa Laboratories 10% Dextrose Injection Sales, Revenue and Gross Margin (2019-2024)
7.6.4 Alfa Laboratories 10% Dextrose Injection Product Offerings
7.6.5 Alfa Laboratories Recent Development
7.7 Drugfield Pharmaceuticals Limited
7.7.1 Drugfield Pharmaceuticals Limited Company Information
7.7.2 Drugfield Pharmaceuticals Limited Introduction and Business Overview
7.7.3 Drugfield Pharmaceuticals Limited 10% Dextrose Injection Sales, Revenue and Gross Margin (2019-2024)
7.7.4 Drugfield Pharmaceuticals Limited 10% Dextrose Injection Product Offerings
7.7.5 Drugfield Pharmaceuticals Limited Recent Development
7.8 Otsuka Pharmaceutical
7.8.1 Otsuka Pharmaceutical Company Information
7.8.2 Otsuka Pharmaceutical Introduction and Business Overview
7.8.3 Otsuka Pharmaceutical 10% Dextrose Injection Sales, Revenue and Gross Margin (2019-2024)
7.8.4 Otsuka Pharmaceutical 10% Dextrose Injection Product Offerings
7.8.5 Otsuka Pharmaceutical Recent Development
7.9 Schwitz Biotech
7.9.1 Schwitz Biotech Company Information
7.9.2 Schwitz Biotech Introduction and Business Overview
7.9.3 Schwitz Biotech 10% Dextrose Injection Sales, Revenue and Gross Margin (2019-2024)
7.9.4 Schwitz Biotech 10% Dextrose Injection Product Offerings
7.9.5 Schwitz Biotech Recent Development
8 Industry Chain Analysis
8.1 10% Dextrose Injection Industrial Chain
8.2 10% Dextrose Injection Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customers Analysis)
8.5 Sales Model and Sales Channels
8.5.1 10% Dextrose Injection Sales Model
8.5.2 Sales Channel
8.5.3 10% Dextrose Injection Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.2 Data Source
10.2 Author Details
10.3 Disclaimer

Companies Mentioned:

B. Braun Medical Inc
ICU Medical
Baxter
Fresenius Kabi
Pfizer
Alfa Laboratories
Drugfield Pharmaceuticals Limited
Otsuka Pharmaceutical
Schwitz Biotech

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.

91制片厂